These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16802838)

  • 1. NICE says no to inhaled insulin: what lessons should we learn?
    Freemantle N
    Pharmacoeconomics; 2006; 24(7):627-9. PubMed ID: 16802838
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled insulin: gone with the wind?
    Mathieu C; Gale EA
    Diabetologia; 2008 Jan; 51(1):1-5. PubMed ID: 18026925
    [No Abstract]   [Full Text] [Related]  

  • 3. Sanofi drops MannKind's inhaled insulin.
    Ratner M
    Nat Biotechnol; 2016 Mar; 34(3):224. PubMed ID: 26963538
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of patients with diabetes mellitus by means of inhaled insulin].
    Simsek S; de Galan BE; Tack CJ; Heine RJ
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):829-32. PubMed ID: 16676511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whither inhaled insulin?
    Young B
    Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):413. PubMed ID: 16932324
    [No Abstract]   [Full Text] [Related]  

  • 6. Exit Exubera. Inhalable insulin is withdrawn due to weak sales.
    Keegan A
    Diabetes Forecast; 2007 Dec; 60(13):19. PubMed ID: 18217270
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
    Mathieu C
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled dry powder insulin for the treatment of diabetes mellitus.
    Setter SM; Levien TL; Iltz JL; Odegard PS; Neumiller JJ; Baker DE; Campbell RK
    Clin Ther; 2007 May; 29(5):795-813. PubMed ID: 17697900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled insulin (exubera).
    Med Lett Drugs Ther; 2006 Jul; 48(1239):57-8. PubMed ID: 16841019
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhaled human insulin.
    Owens DR; Grimley J; Kirkpatrick P
    Nat Rev Drug Discov; 2006 May; 5(5):371-2. PubMed ID: 16802444
    [No Abstract]   [Full Text] [Related]  

  • 11. Willingness to pay for inhaled insulin: a contingent valuation approach.
    Sadri H; MacKeigan LD; Leiter LA; Einarson TR
    Pharmacoeconomics; 2005; 23(12):1215-27. PubMed ID: 16336016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled insulin: the solution for suboptimal diabetes control?
    Amiel SA
    Clin Med (Lond); 2007 Oct; 7(5):430-2. PubMed ID: 17990701
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled human insulin (Exubera): a review of its use in adult patients with diabetes mellitus.
    Dunn C; Curran MP
    Drugs; 2006; 66(7):1013-32. PubMed ID: 16740022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
    Pham DQ; Cohen H; Chu V
    J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhaled human insulin (Exubera): a revolution?].
    Daubresse JC; Sternon J
    Rev Med Brux; 2006; 27(6):493-7. PubMed ID: 17256415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin inhalation (Aradigm Corporation). NN 1998.
    Drugs R D; 1999 Aug; 2(2):110-1. PubMed ID: 10820652
    [No Abstract]   [Full Text] [Related]  

  • 17. Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials.
    Hollander PA; Krasner A; Klioze S; Schwartz P; Duggan W
    Diabetes Care; 2007 Oct; 30(10):2508-10. PubMed ID: 17536080
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
    Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.
    Kanna B; Abreu-Pacheco H
    Diabetes Care; 2007 Feb; 30(2):445-6; author reply 446. PubMed ID: 17259531
    [No Abstract]   [Full Text] [Related]  

  • 20. Years in the making: inhaled insulin has finally arrived.
    Strain J
    S D Med; 2006 Jul; 59(7):301-2. PubMed ID: 16895053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.